The Problem
The Problem
The Problem
Over 80% of global genomic datasets come from European populations, leaving critical gaps in drug discovery, missed therapeutic targets, and inequitable outcomes.
- Biased data → biased care
- Longer, costlier discovery cycles
- Communities excluded from the value their data creates
Our Answer
The Problem
The Problem
IndyGeneUS Bio fuses differentiated African genomic data with quantum‑AI discovery engines on blockchain rails to identify novel, actionable targets faster—while returning value to data contributors.
- Differentiated Data Quantum + AI Blockchain Ownership
How We're Different
Quantum + AI
Digital Twin Technology
Differentiated Data
Advanced analytics to accelerate therapeutic discovery.
Differentiated Data
Digital Twin Technology
Differentiated Data
The world’s most comprehensive African diaspora genomic biobank.
Digital Twin Technology
Digital Twin Technology
Digital Twin Technology
Secure, precise modeling of health and disease at scale.
Bio-fintech Model
Digital Twin Technology
Digital Twin Technology
Transforming genomic insights into sustainable wealth creation.
Who We Are
Mission
Mission
Mission
To revolutionize global biomedicine by harnessing African diaspora differentiated genomic data, quantum computing, AI, and digital twin technology to accelerate gene target discovery and power next generation therapeutics.
Vision
Mission
Mission
Build the world’s first bio-fintech ecosystem that transforms 1M+ African diaspora genomes into digital twins, analyzed with quantum-powered AI, to create a trillion-dollar bio-economy—where no child, family, or community is left behind because their genomic data was ignored.
Impact
Mission
Impact
Health, wealth, and longevity—delivered through equitable data ecosystems.
- Health Equity: Oncology, rare disease, infectious disease targets informed by African diversity.
- Economic Empowerment: Tokenized models return value to data contributors.
- Longevity: Pathway discoveries that extend healthy lifespan globally.